This inventor holds 29 USPTO granted patents and 26 published patent applications, plus 5 CIPO patents and 7 EPO patents, primarily in Nucleic Acid Delivery. Top assignees: Protiva Biotherapeutics, Inc., Arbutus Biopharma Corporation, The University of British Columbia. Active years: 2005-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Burnaby, CA (2012 - 2018)
- Vancouver, CA (2005 - 2024)
Company Filing History:
19 out of 46 
7 out of 57 
2 out of 966 
Years Active: 2005-2026
Areas of Expertise:
Title: Innovations and Contributions of Lorne Ralph Palmer in Nucleic Acid Delivery
Introduction: Lorne Ralph Palmer, based in Vancouver, Canada, is an influential inventor with an impressive portfolio of 26 patents. His groundbreaking work focuses on advancing the field of nucleic acid delivery, which has significant implications for therapeutic applications.
Latest Patents: Among his latest innovations, Palmer has introduced novel non-liposomal systems for nucleic acid delivery. This invention presents stable lipid particles with a non-lamellar structure that can effectively encapsulate therapeutic agents. Notably, his stable nucleic acid-lipid particles (SNALP) can incorporate interfering RNA, enhancing the methods for delivering and administering these vital therapeutic agents.
Another remarkable patent by Palmer encompasses a new apparatus and manufacturing methods for producing liposomes. This innovative process involves the continuous dilution of a lipid solution with a buffer solution in a mixing chamber, which successfully creates liposomes. The manufacturing process aims to simplify the production methods while ensuring stability and efficacy.
Career Highlights: Lorne Ralph Palmer has significantly contributed to the biotechnology sector through his tenure at companies such as Protiva Biotherapeutics, Inc. and Arbutus Biopharma Corporation. His work at these organizations has propelled advances in drug delivery systems and has positioned him as a leading figure in his field.
Collaborations: Throughout his career, Palmer has collaborated with prominent professionals, including Ian MacLachlan and Lloyd B. Jeffs. These partnerships have facilitated the sharing of ideas and knowledge, further enriching the innovations emerging from his research and inventions.
Conclusion: Lorne Ralph Palmer’s contributions to the field of nucleic acid delivery demonstrate his commitment to innovation and therapeutic advancements. With 26 patents to his name, his ongoing work promises to reshape drug delivery methodologies, benefiting countless patients worldwide. His ability to collaborate with other experts and to create groundbreaking inventions solidifies his status as a significant innovator in the biotechnology industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile